Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Fluorescent biomarkers
  • Track 1-2Blood-based biomarkers
  • Track 1-3Pro-inflammatory biomarkers
  • Track 1-4Hematological biomarkers
  • Track 1-5Obesity biomarkers
  • Track 2-1Protein biomarkers
  • Track 2-2Nucleic acid based biomarkers
  • Track 2-3Small molecule biomarkers
  • Track 2-4Lipid biomarkers
  • Track 2-5MicroRNA biomarkers
  • Track 3-1Pharmacodynamic cancer biomarkers
  • Track 3-2Biomarkers in cancer research and medicine
  • Track 3-3Cancer epidemiology and biomarkers
  • Track 3-4Immuno oncology biomarkers
  • Track 3-5Biomarkers for the prognosis of cancer and prediction of treatment
  • Track 3-6Use of biomarkers for developing drug targets
  • Track 4-1Disease-related biomarkers
  • Track 4-2Asthma biomarkers
  • Track 4-3Biomarkers for Cardiovascular diseases
  • Track 4-4Biomarkers for neurological disorders
  • Track 4-5Biomarkers for Rheumatic diseases
  • Track 4-6Alzheimers biomarker
  • Track 5-1Next generation sequencing for the discovery of Biomarkers
  • Track 5-2Genome sequencing for the discovery of Biomarkers
  • Track 5-3MicroRNA sequencing for the prediction of diseases
  • Track 5-4Using SNP as biomarkers
  • Track 5-5Genome biomarkers
  • Track 5-6Cell proliferation markers
  • Track 5-7Cytogenetic biomarkers
  • Track 5-8Oxidative stress biomarkers
  • Track 6-1Transcription analysis and transcriptional profiling
  • Track 6-2Gene expression analysis in biomarker research
  • Track 6-3Microarray data analysis
  • Track 7-1Imaging biomarkers
  • Track 7-2Quantitative imaging biomarkers
  • Track 8-1Biomarkers in Drug development
  • Track 8-2Predictive biomarkers
  • Track 8-3Prognostic biomarkers
  • Track 8-4Clinical biomarkers
  • Track 9-1Epigenetic biomarkers
  • Track 9-2Methylation biomarkers
  • Track 9-3Pharmacodynamic biomarkers
  • Track 9-4Exposure and genetic susceptibility of biochemicals
  • Track 9-5Pharmacodynamic and toxicodynamic interactions to the pathological and biochemical changes
  • Track 10-1Biomarker discovery and Identification methods
  • Track 10-2Translational biomarkers in drug development
  • Track 10-3Biomarker discovery and clinical validations
  • Track 11-1Biomarkers and surrogate endpoints for clinical trails
  • Track 11-2Diagnostics and Biomarker development
  • Track 11-3Biomarkers as Part of the Clinical Development Process
  • Track 12-1Genomic and proteomic approaches
  • Track 12-2Metabolomics and metabonomics methods
  • Track 12-3Transcriptomics for the discovery of Biomarkers
  • Track 12-4Data Mining Methods
  • Track 12-5Application of Bioinformatics in Biomarkers research
  • Track 13-1Nanotechnology based biomarker detection
  • Track 13-2Interaction of biomarkers with nanoparticles
  • Track 13-3Mining for biomarkers with nanotechnology
  • Track 13-4Early detection of cancer using nanotechnology
  • Track 13-5Applications of nanotechnology in Biomarkers
  • Track 14-1Improving the efficiency of biomarker identification
  • Track 14-2Methodology and applications of Biomarker identification
  • Track 14-3Chromatographic techniques
  • Track 14-4Molecular dynamics and molecular imaging
  • Track 14-5Biomarker identification and assay development
  • Track 15-1Next generation biomarkers for predicting toxicity
  • Track 15-2Translational Biomarkers in toxicology
  • Track 15-3Biomarkers as indicator of toxicity in clinical trails
  • Track 16-1Genetic testing of Molecular Biomarkers
  • Track 16-2Biomarker testing for diseases
  • Track 16-3Biomarker testing and diagnosis
  • Track 17-1Biomarkers and new therapeutic strategies
  • Track 17-2Biomarker research in Neurology
  • Track 17-3Discovery of novel biomarkers of exposure for dietary, environmental, and metabolic cancer risk factors
  • Track 17-4Challenges in Biomarkers research
  • Track 18-1Clinical Applications in Cardiovascular diseases
  • Track 18-2Application of Biomarkers in the development of drugs
  • Track 18-3Vaccine and drug development
  • Track 18-4Other Applications of Biomarkers